| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/11/2008 | CA2614069A1 Nucleic acid isolation using polidocanol and derivatives |
| 06/10/2008 | US7385123 Process for preparing ketocarotenoids in genetically modified organisms |
| 06/10/2008 | US7385121 Plants and seeds of corn variety I082691 |
| 06/10/2008 | US7385119 Garden bean named H24953 |
| 06/10/2008 | US7385118 Soybean cultivar 6424090 |
| 06/10/2008 | US7385117 Soybean variety 0367478 |
| 06/10/2008 | US7385116 Soybean variety 0240187 |
| 06/10/2008 | US7385115 Soybean cultivar 6723322 |
| 06/10/2008 | US7385114 Soybean cultivar SG4377NRR |
| 06/10/2008 | US7385112 Soybean variety 4367308 |
| 06/10/2008 | US7385109 Soybean variety 4540394 |
| 06/10/2008 | US7385107 Insect-resistant transgenic plants transformed with CryET33 and CryET34-encoding nucleic acids |
| 06/10/2008 | US7385106 Comprises nucleotide sequences coding polypeptied for use in generation of stress and drought resistant plant |
| 06/10/2008 | US7385105 Root active promoters and uses thereof |
| 06/10/2008 | US7385104 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch |
| 06/10/2008 | US7385103 Animal model, cells, and treatment for malignant melanoma |
| 06/10/2008 | US7385053 Functionalized compositions for improved immobilization |
| 06/10/2008 | US7385048 Promoters and utilization thereof |
| 06/10/2008 | US7385047 Isolated polypeptide and nucleic acid sequences derived from S. pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides; bactericides; vaccines; antibodies; target screening |
| 06/10/2008 | US7385046 Sequence-determined DNA fragments encoding ethylene responsive element binding proteins |
| 06/10/2008 | US7385045 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 06/10/2008 | US7385044 Comprises nucleotide sequences coding fusion protein ligand which binds major histocompatibility complex and human leukocyte antigen for use in detection and prevention of infections, cancer andautoimmune disorders |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385034 Complementary DNAs encoding proteins with signal peptides |
| 06/10/2008 | US7385033 PRO12970 polypeptides |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7385031 PRO6097 polypeptides |
| 06/10/2008 | US7385030 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384923 Liposomes |
| 06/10/2008 | US7384913 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 06/10/2008 | US7384911 Also for preventing and treating bacterial and fungal diseases in mammals; agricultural applications; |
| 06/10/2008 | US7384788 Regulator/promoter for tunable gene expression and metabolite sensing |
| 06/10/2008 | US7384787 converting a polypeptide having predominant esterase and/or lipase catalytic activity to a polypeptide having predominant perhydrolase activity; genetic engineering; hydrolase enzymes |
| 06/10/2008 | US7384784 Pax-encoding vector and use thereof |
| 06/10/2008 | US7384780 Hybridization method and hybridization equipment |
| 06/10/2008 | US7384776 Expression vectors for increasing protein yield from a cell culture and methods of use thereof |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384774 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 06/10/2008 | US7384771 Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
| 06/10/2008 | US7384769 Using calibrators, primers, probes and nucleic acid polymerase |
| 06/10/2008 | US7384768 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 06/10/2008 | US7384767 Nucleic acid encoding an interleukin-9 receptor variant |
| 06/10/2008 | US7384761 Methods of identifying an agent capable of interfering with Rad9 dephosphorylation |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384755 Sensitive to cAMP; fluorescent signal in response to depolarization |
| 06/10/2008 | US7384750 Nucleic acid sequences having characteristics of enhanced expression in human neuroblastoma with favorable prognosis based on comparison between human neuroblastoma with favorable prognosis and human neuroblastoma with unfavorable prognosis |
| 06/10/2008 | US7384747 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 06/10/2008 | US7384746 Charge tags and the separation of nucleic acid molecules |
| 06/10/2008 | US7384744 comprising a gene which codes for a protein of interest, functionally linked to a hamster-ubiquitin/S27a-promoter and a gene which codes for a fluorescent protein; internal ribosomal entry site (IRES) |
| 06/10/2008 | US7384741 Using internal transcribed spacer sequences to classify/distinguish between microorganismal strains |
| 06/10/2008 | US7384738 Retrovirus-based genomic screening |
| 06/10/2008 | US7384737 Coding microarrays of biopolymers on solid support; obtain array, incubate with labelled nucleotides containg blocking groups, incorporate nucleotides into microarrays, remove blocking group, monitor microarrays |
| 06/10/2008 | US7384736 Detecting modulators of cytokine activity; bronchodilator agents; antiarthritic agents; glucocorticoids; leukotriene antagonists; corticosteroids |
| 06/10/2008 | US7384644 Modified Vaccinia Ankara virus variant |
| 06/10/2008 | US7384643 genetically engineered to be incapable of expressing a native A41L protein; binds to chemokines in the CXC group. |
| 06/10/2008 | US7384638 includes polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides |
| 06/10/2008 | US7384635 Protein variants of naturally occurring allergens |
| 06/10/2008 | US7384633 Human type antihuman IgE receptor antibody and fragment |
| 06/10/2008 | US7384632 for prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy |
| 06/10/2008 | US7384387 High throughput mass spectrometry |
| 06/10/2008 | CA2423481C Isolated peptides which bind to hla-c molecules and uses thereof |
| 06/10/2008 | CA2369869C Process for producing subunit peptide originating in polymer protein |
| 06/10/2008 | CA2365262C Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2355897C Selecting animals for parentally imprinted traits |
| 06/10/2008 | CA2286330C Anti-vegf antibodies |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2247074C Dna molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof |
| 06/10/2008 | CA2229028C Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/10/2008 | CA2202923C Human epithelial colon immortalised cell line |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/10/2008 | CA2179420C Soft agar penetration-defective mutants |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/10/2008 | CA2113562C Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 06/05/2008 | WO2008067560A2 Compositions and methods of sphingosine kinase inhibitors for use thereof in cancer therapy |
| 06/05/2008 | WO2008067526A2 Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers |
| 06/05/2008 | WO2008067423A2 Methods of improving the introduction of dna into bacterial cells |
| 06/05/2008 | WO2008067398A2 Alternative export pathways for vector expressed rna interference |
| 06/05/2008 | WO2008067382A2 Rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions |
| 06/05/2008 | WO2008067373A2 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 06/05/2008 | WO2008067178A2 Electroporation cuvette with high field intensity and field-induced agitation |
| 06/05/2008 | WO2008067089A2 Light-regulated transcription system for use in prokaryotic organisms |
| 06/05/2008 | WO2008067025A2 Oncolytic adenoviruses and uses thereof |
| 06/05/2008 | WO2008066931A2 Bacillus licheniformis chromosome |
| 06/05/2008 | WO2008066776A2 Methods for treating hypercholesterolemia |
| 06/05/2008 | WO2008066608A2 A secreted luciferase fluorescent protein conjugate nucleic acid construct and uses thereof |
| 06/05/2008 | WO2008066498A1 Cancer-related protein kinases |
| 06/05/2008 | WO2008066199A1 Method of inducing differentiation of embryonic stem cells into insulin-secreting cells, insulin-secreting cells induced by the method and use of the same |
| 06/05/2008 | WO2008066165A1 Primer set for amplification of sult1a1 gene, reagent for amplification of sult1a1 gene comprising the same, and use of the same |
| 06/05/2008 | WO2008066164A1 Primer set for amplification of obesity gene, reagent for amplification of obesity gene comprising the primer set, and use of the primer set |
| 06/05/2008 | WO2008066163A1 Primer set for amplification of cyp2c9 gene, reagent for amplification of cyp2c9 gene comprising the same, and use of the same |
| 06/05/2008 | WO2008066162A1 Primer set for amplification of cyp2c19 gene, reagent for amplification of cyp2c19 gene comprising the same, and use of the same |
| 06/05/2008 | WO2008066161A1 Primer set for amplification of nat2 gene, reagent for amplification of nat2 gene comprising the same, and use of the same |
| 06/05/2008 | WO2008066136A1 Primer set for amplification of ugt1a1 gene, reagent for amplification of ugt1a1 gene comprising the same, and use of the same |
| 06/05/2008 | WO2008066057A1 Control of cell proliferation targeted for iqgap3 |
| 06/05/2008 | WO2008066032A1 Lymphangiogenesis inhibitory factor |
| 06/05/2008 | WO2008066018A1 Novel alcohol dehydrogenase, gene for the alcohol dehydrogenase, vector, transformant, and method for production of optically active alcohol by using them |
| 06/05/2008 | WO2008066002A1 Method for detection of apple mosaic virus, primer set for the detection, and kit for the detection |